SR0136LRB103 31458 MST 59199 r

1
SENATE RESOLUTION

 
2    WHEREAS, Respiratory Syncytial Virus disease (RSV) is a
3highly transmissible, seasonal virus that can have severe and
4unpredictable outcomes for infants, including hospitalization;
5and
 
6    WHEREAS, Nearly all children will be infected with RSV by
7age two, and most infants requiring hospitalization were
8previously healthy and born at term; and
 
9    WHEREAS, RSV is the leading cause of hospitalization among
10infants in the U.S.; and
 
11    WHEREAS, RSV is the most common cause of bronchiolitis
12(inflammation of the small airways in the lung) and pneumonia
13(infection of the lungs) in children younger than one year of
14age in the U.S.; and
 
15    WHEREAS, The current RSV season has resulted in
16significant morbidity and increased mortality; and
 
17    WHEREAS, In the U.S., RSV infections typically occur
18during late fall, winter, and early spring, which means urgent
19preparation is needed; and
 

 

 

SR0136- 2 -LRB103 31458 MST 59199 r

1    WHEREAS, Monoclonal antibodies show promise in
2preventative protection against RSV; and
 
3    WHEREAS, RSV disproportionally affects infants with
4Medicaid coverage, Native Americans, and Alaskan Natives; and
 
5    WHEREAS, The Vaccines For Children (VFC) program is a
6federally-funded program that provides vaccines at no cost to
7children who might not otherwise be vaccinated because of
8inability to pay; and
 
9    WHEREAS, VFC coverage is critical to ensure equity and
10access for all infants in order to have the greatest impact on
11disease burden; therefore, be it
 
12    RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
13ASSEMBLY OF THE STATE OF ILLINOIS, that we urge the Centers for
14Disease Control and Prevention to include new RSV immunization
15technologies (including vaccines and monoclonal antibodies),
16within the federal VFC program if the Advisory Committee on
17Immunization Practices of the Centers for Disease Control and
18Prevention issues administrative recommendations that are
19subsequently approved by the Director of the Centers for
20Disease Control and Prevention; and be it further
 
21    RESOLVED, That suitable copies of this resolution be

 

 

SR0136- 3 -LRB103 31458 MST 59199 r

1delivered to Director of the Centers for Disease Control and
2Prevention Rochelle Walensky, Administrator of the Centers for
3Medicare and Medicaid Services (CMS) Chiquita Brooks-LaSure,
4and Secretary of the Department of Health and Human Services
5Xavier Becerra.